Contract development and manufacturing organisation Recipharm has appointed Shabbir Mostafa as Director, Business Management UK & Ireland. He will be responsible for supporting customers in the UK and Ireland and driving sales of Recipharm’s manufacturing services.
Boehringer Ingelheim’s Humira biosimilar meets endpoint
Latest NewsBoehringer Ingelheim has presented detailed pivotal double-blinded Phase III data, which prove comparability of its biosimilar candidate BI695501 to Humira in patients with moderate to severe Rheumatoid Arthritis.
Medicxi launches €267m fund
Latest NewsNovartis and Alphabet/Google asset Verily Life Sciences LLC has co-invested into the late stage fund designed to finance programmes with up to €25m post clinical proof of concept.
Germany is blocking EU Unitary Patent Court
Latest NewsGermany’s Constitutional Court has stopped the government from ratifying the EU’s Unitary Patent Package. At the time of the announcement, The German Bundestag and Council of Federal states had already adopted and signed the legislation.
Recipharm: Strategic appointment
AppointmentsAbivax Ebola antiviral gets financing
Latest NewsFrench virology company Abivac will receive €390,000 for the development of a polyclonal antibody cocktail to fight Ebola.
LowCross-Buffer
ProductsAntibody and sample diluent for minimizing nonspecific binding, cross-reactivities and matrix effects in immunoassays.
Centogene raises a €25m in Series A financing
Latest NewsOrphan diseases diagnostics specialist Centogene AG said it will use the funds for biomarker and CDx development based on its proprietary CentoMD mutation database.
Virbac: Managing global operations
AppointmentsBonesupport is planning €60m IPO
Latest NewsSwedish orthobiologics company Bonesupport Holding AB announced on Sunday it will go public at Nasdaq Stockholm.
Targovax raises €21m in private placement
Latest NewsNorwegian cancer med developer Targovax ASA has doubled its cash and cash equivalents as of 31 December 2016 by raising NOK200m (€21m) in a private placement of new shares.